Item 9 Labs Corp.
INLB
$0.00
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -5.91M | -3.42M | -3.26M | -18.45M | -5.47M |
| Total Depreciation and Amortization | 432.80K | 442.50K | 443.10K | 511.70K | 498.90K |
| Total Amortization of Deferred Charges | 498.40K | 500.40K | 504.50K | 1.50M | 583.50K |
| Total Other Non-Cash Items | 1.15M | 749.20K | 141.40K | 12.26M | 1.15M |
| Change in Net Operating Assets | 3.98M | 2.03M | 834.00K | 3.94M | 843.50K |
| Cash from Operations | 150.10K | 302.60K | -1.33M | -238.20K | -2.39M |
| Capital Expenditure | -62.80K | 1.50K | -6.80K | -1.41M | 316.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -3.30K | -70.00K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 21.50K | -3.60K |
| Cash from Investing | -62.80K | 1.50K | -6.80K | -1.39M | 243.00K |
| Total Debt Issued | 249.20K | -12.50K | 1.60M | 2.13M | 3.30M |
| Total Debt Repaid | -199.20K | -212.20K | -319.90K | -901.20K | -1.06M |
| Issuance of Common Stock | -- | -- | -- | 101.90K | 267.10K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -55.00K | -- | -- | -61.00K | -27.70K |
| Cash from Financing | -5.00K | -224.70K | 1.28M | 1.27M | 2.48M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 82.30K | 79.40K | -63.90K | -356.00K | 336.50K |